(Q33866428)

29 July 2017

title

Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma (English)

1 reference

29 July 2017

1 reference

1 reference

Yu-Ping Xiao

1 reference

29 July 2017

Dong-Ying Wu

series ordinal

1 reference

29 July 2017

Lei Xu

series ordinal

1 reference

29 July 2017

Yan Xin

series ordinal

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

World Journal of Gastroenterology

29 July 2017

1 reference

inferred from page(s)

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

3766-3769

1 reference

Ets1 as a marker of malignant potential in gastric carcinoma

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Loss of fragile histidine triad protein in human hepatocellular carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Impaired FHIT expression characterizes serous ovarian carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.

28 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Down-regulation of fragile histidine triad expression in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Loss of Fhit protein in carcinoma of primary and secondary müllerian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I23.3766

Quantitation and detection of deletion in tumor mitochondrial DNA by microarray technique

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

FHIT expression and hypermethylation in esophageal squamous cell carcinoma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087473

[Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance]

29 October 2018

1 reference

12 December 2020

FHIT gene in gastric cancer: association with tumour progression and prognosis

1 reference

12 December 2020

Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival

1 reference

12 December 2020

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V12.I23.3766

1 reference

29 July 2017

1 reference

29 July 2017

1 reference